Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-29

Clinical Trial Update: Morphine in Moderate Obstructive Sleep Apnoea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating morphine for moderate obstructive sleep apnea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Obstructive Sleep Apnoea | Phase 3 | Status: TERMINATED